Search Options Stock News and Analysis from Schaeffer's

AstraZeneca Stock Downgraded on Drug Trial Results

https://www.schaeffersresearch.com/content/news/2024/09/13/astrazeneca-stock-downgraded-on-drug-trial-results

9/13/2024 9:20 AM

Biopharmaceutical stock AstraZeneca PLC (NASDAQ:AZN) is 1.3% lower before the open, after a bear note from Deutsche Bank. The analyst downgraded AZN to "sell" from "hold" and lowered its price target,...

Biotech Stock Soars on AstraZeneca Buyout

https://www.schaeffersresearch.com/content/news/2024/03/19/biotech-stock-soars-on-astrazeneca-buyout

3/19/2024 10:50 AM

Fusion Pharmaceuticals Inc (NASDAQ:FUSN) stock is skyrocketing today, after news that AstraZeneca (AZN) is acquiring the Canadian biotech company for $2.4 billion, or $21 per share. As part of the de...

Acquisitions Push 2 Pharma Stocks in Opposite Directions

https://www.schaeffersresearch.com/content/news/2023/12/26/acquisitions-push-2-pharma-stocks-in-opposite-directions

12/26/2023 10:24 AM

Pharmaceutical giants AstraZeneca plc (NASDAQ:AZN) and Bristol-Myers Squibb Co (NYSE:BMY) announced new acquisitions today. The former acquired China's Gracell Biotechnologies (GRCL) for $1.2 bill...

Biopharma Stock Gaps Lower After Trial Disappoints

https://www.schaeffersresearch.com/content/news/2023/07/03/biopharma-stock-gaps-lower-after-trial-disappoints

7/3/2023 10:53 AM

AstraZeneca PLC (NASDAQ:AZN) is gapping lower today, after the biopharmaceutical name's lung cancer drug disappointed investors in a late-stage trial. At last glance, AZN was down 7.2% at $66.41 and...

Options Traders Target Pharma Stock on FDA Buzz

https://www.schaeffersresearch.com/content/options/2023/06/06/options-traders-target-pharma-stock-on-fda-buzz

6/6/2023 3:06 PM

Options traders are blasting pharma stock AstraZeneca PLC (NASDAQ:AZN) today, after the U.S. Food and Drug Administration (FDA) failed to find any safety issues with the company's experimental respi...

PEOPLE ALSO SEARCH FOR

-intraday-options-activity

IXIC

LLY